Balkrishan Kalra - 03 Mar 2026 Form 4 Insider Report for Genpact LTD (G)

Signature
/s/ Thomas D. Scholtes, as Attorney-in-fact for Balkrishan Kalra
Issuer symbol
G
Transactions as of
03 Mar 2026
Net transactions value
-$114,156
Form type
4
Filing time
05 Mar 2026, 16:43:27 UTC
Previous filing
03 Feb 2026
Next filing
12 Mar 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Kalra Balkrishan President and CEO, Director C/O GENPACT LLC, 521 FIFTH AVENUE, 14TH FLOOR, NEW YORK /s/ Thomas D. Scholtes, as Attorney-in-fact for Balkrishan Kalra 05 Mar 2026 0001768217

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction G Common Shares Award +27,160 +5.5% $0.000000* 525,007 03 Mar 2026 Direct F1, F2
transaction G Common Shares Options Exercise +2,800 +0.53% $27.65* 527,807 04 Mar 2026 Direct
transaction G Common Shares Sale $114,156 -2,800 -0.53% $40.77 525,007 04 Mar 2026 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction G Employee Stock Option (Right to Buy) Options Exercise -2,800 -100% $0.000000* 0 04 Mar 2026 Common Shares 2,800 $27.65 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person was granted performance share units (PSUs) on March 15, 2023 that were subject to performance conditions which have been satisfied. Each PSU represents the contingent right to receive one common share. The PSUs will vest on March 10, 2026 subject to the reporting person's continued service through such date.
F2 Includes 587 shares acquired under the Genpact Employee Stock Purchase Plan (ESPP) since the reporting person's Form 4 filed on February 3, 2026. The reporting person currently holds a total of 8,962 shares under the ESPP.
F3 The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $40.74 to $40.771. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F4 The option vested 50% on January 10, 2019 and the remainder on January 10, 2021.